Here's What Pushed Aurinia Pharmaceuticals Inc. Up 16.8% in September [The Motley Fool]
Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.auriniapharma.com
Company Research
Source: The Motley Fool
Steady progress for the company's experimental lupus treatment took an important step forward Cory Renauer ( TMFang4apples ) Oct 3, 2018 at 5:49PM What happened Shares of Aurinia Pharmaceuticals Inc. ( NASDAQ:AUPH ) , a biotechnology company developing an experimental new lupus therapy, rose 16.8% in September, according to data from S&P Global Market Intelligence . Analyst attention following an important step forward for the company's lead candidate pushed the stock higher. So what Aurinia's lead candidate, voclosporin, is in a pivotal study that could make it the first therapy specifically approved for the treatment of lupus nephritis. Late in September, the company finished enrolling patients into the Aurora study -- which means 52-week kidney response data should be ready in 2019. Image source: Getty Images. Estimates vary, but p
Show less
Read more
Impact Snapshot
Event Time:
AUPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUPH alerts
High impacting Aurinia Pharmaceuticals Inc - Common Shares news events
Weekly update
A roundup of the hottest topics
AUPH
News
- UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference [Yahoo! Finance]Yahoo! Finance
- UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceBusiness Wire
- Pelthos Therapeutics Establishes Board of Directors [Yahoo! Finance]Yahoo! Finance
- Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024Business Wire
- Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor ConferenceBusiness Wire
AUPH
Earnings
- 2/15/24 - Miss
AUPH
Sec Filings
- 3/20/24 - Form SC
- 3/7/24 - Form 4
- 3/7/24 - Form 4
- AUPH's page on the SEC website